References
- Jones D. B. Decision-making in the management of microbial keratitis. Ophthalmology 1981; 88: 814–820
- Liesegang T. J., Forster R. K. Spectrum of microbial keratitis in South Florida. Am. J. Ophthalmol. 1981; 90: 38–47
- Asbell P., Stenson S. Ulcerative keratitis. Survey of thirty years laboratory experience. Arch. Ophthalmol. 1982; 100: 77–80
- Wilson L. A. Acute bacterial infection of the eye: Bacterial keratitis and endophthalmitis. Trans. Ophthalmol. Soc. U.K. 1986; 105: 43–60
- Baum J. Therapy for ocular bacterial infection. Trans. Ophthalmol. Soc. U.K. IPS 1986; 69–77
- Leibowitz H. M. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am. J. Ophthalmol. 1991; 112: 34S–47S
- Jones S., Cohen E. J., Arentsen J. J., Laibson P. R. Ocular streptococcal infections. Cornea 1988; 7: 295–299
- Samples J. R., Baumgartner S. D., Binder P. S. Infectious crystalline keratopathy: an electron microscope analysis. Cornea 1985; 4: 118–126
- Meisler D. M., Langston R. H.S., Naab T. J., Aaby A. A., McMahon J. T., Tubbs R. R. Infectious crystalline keratopathy. Am. J. Ophthalmol. 1984; 97: 337–343
- Ormerod L. D., Ruoff K. L., Meisler D. M., Wasson P. J., Kintner J. C., Dunn S. P., Lass J. H., van de Rijn I. Infectious crystalline keratopathy. Role of nutritionally variant streptococci and other bacterial factors. Ophthalmology 1991; 98: 159–169
- Murray B. E. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. J. Infect. Dis. 1991; 163: 1185–1194
- Neu H. C. Bacterial resistance to fluoroquinolones. Rev. Infect. Dis. 1988; 10: 57–63
- Neu H. C. Microbiological aspects of fluoroquinolones. Am. J. Ophthalmol. 1991; 112: 15S–24S
- Cheung R. P., DiPiro J. T. Vancomycin: An update. Pharmacotherapy 1986; 6: 153–169
- Parenti F. Structure and mechanism of action of teicoplanin. J. Hosp. Infect 1986; 7(A)79–83
- Parenti M. A., Hatfield S. M., Leyden J. J. Mupirocin: A topical antibiotic with a unique structure and mechanism. Clin. Pharm. 1987; 6: 761–770
- Bernbaum J., Kahan F. M., Kropp H., MacDonald J. S. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin. Am. J. Med. 1985; 78(6A)3–21
- Lass J. H., Mack R. J., Imperia P. S., Mallick K., Lazarus H. M. An in vitro analysis of aminoglycoside corneal epithelial toxicity. Curr. Eye Res. 1989; 8: 299–304
- Cutarelli P. E., Mack R. J., Lazarus H. M., Jacobs M. R., Lass J. H. An in vitro analysis of cephalosporin corneal epithelial toxicity. J. Toxicol. Cut. Ocular Toxicol. 1990; 9: 99–107
- Cutarelli P. E., Lass J. H., Lazarus H. M., Putman S. C., Jacobs M. R. Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity. Curr. Eye Res. 1991; 10: 557–563
- The National Committee for Clinical Laboratory Standards. Tentative Standard M7T2. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA 1988
- Havener W. H. Wetting agents. “Ocular Pharmacology—, W. H. Havener. C.V. Mosby, St Louis 1983; 622–634
- Martin B. M., Gimbrone M. A., Unanue E. R., Cotran R. S. Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J. Immunol. 1981; 126: 1510–1515